HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].

AbstractAIMS:
Urothelial neoplasms in patients 19 years or younger are rare, with conflicting data regarding clinical outcome and no molecular data available.
METHODS:
Urothelial tumors of 14 patients 4 to 19 years old were identified, reclassified according to the 2004 WHO classification and data on presentation, risk factors and outcome were collected. 14 cases were microdissected and extensive molecular analyses were done, including FGFR3 and TP 53 mutation screening, Comparative Genomic Hybridisation (CGH), Urovysion FISH analysis, PCR for HPV, microsatellite analysis using an extended NIH consensus panel for detection of microsatellite instability (MSI) and 6 LOH markers on chromosome arms 17p, 9p and 9q and immunohistochemistry for TP 53, MIB1, CK20 and the mismatch repair proteins hMSH2, hMLH1 and hMSH6.
RESULTS:
Based on the 2004 WHO classification, 1 urothelial papilloma, 7 PUNLMPs, 5 low grade, and 1 high grade papillary urothelial cancers were included. There were no multifocal tumors and only 1 patient had recurrence. All patients were alive with no evidence of disease (4.5 years follow-up). We did not find mutations in FGFR3, deletions of chromosome arms 9p, 9q or 17p, MSI or MRP loss or HPV positivity. Chromosomal alterations in CGH, urothelial dedifferentiation with CK20 over-expression or aneuploidy were rare and only detected in 3 cases. One TP53 mutation was found in the only tumor with overexpression of TP53.
CONCLUSIONS:
Urothelial neoplasms in individuals younger than 20 years have predominantly a low grade and favourable clinical outcome. The most frequent genetic alterations found in elderly patients are extremely rare. Urothelial neoplasms in young patients could represent a biologically distinct form of bladder disease with lack of genetic instability in most cases.
AuthorsJohannes Giedl, Peter J Wild, Robert Stoehr, Kerstin Junker, Stefan Boehm, Johanna M M van Oers, Ellen C Zwarthoff, Hagen Blaszyk, Samson W Fine, Peter A Humphrey, Louis P Dehner, Mahul B Amin, Jonathan I Epstein, Arndt Hartmann
JournalVerhandlungen der Deutschen Gesellschaft fur Pathologie (Verh Dtsch Ges Pathol) Vol. 90 Pg. 253-63 ( 2006) ISSN: 0070-4113 [Print] Germany
Vernacular TitleUrotheltumoren bei Kindern und Jugendlichen (< 20 Jahre) haben nur selten molekulare Veränderungen und eine gute Prognose.
PMID17867604 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Child
  • Child, Preschool
  • Humans
  • Hybridization, Genetic
  • In Situ Hybridization, Fluorescence
  • Mutation
  • Nucleic Acid Hybridization
  • Polymerase Chain Reaction
  • Treatment Outcome
  • Urinary Bladder Neoplasms (genetics, pathology)
  • Urologic Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: